首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma.
【24h】

Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma.

机译:格拉斯哥的预后评分与输血量和肝癌肝切除术后并发症有关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Systemic inflammation before surgery, as evidenced by the Glasgow prognostic score (GPS), predicts postoperative complications and cancer-specific survival in various types of cancer. The aim of this study was to evaluate the significance GPS in hepatic resection for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Sixty-six patients who underwent elective hepatic resections for HCC were include in the study. Patients were classified into three groups: GPS 0 [C-reactive protein (CRP)/=3.5 g/dl, n = 54], GPS 1 [CRP >1.0 mg/dl or serum albumin <3.5 g/dl, n = 11], and GPS 2 [CRP>1.0 mg/dl and serum albumin <3.5 g/dl, n = 1]. We retrospectively examined the association between GPS (0 or 1) and perioperative clinical variables and outcome. RESULTS: In univariate analysis, GPS 0 patients had significantly better preoperative the retention rate of indocyanine green at 15 minutes (ICGR15) (p=0.0418), Child-Pugh classification (p = 0.0075) and model for end-stage liver disease score (p = 0.0007) than did GPS 1 patients. In multivariate analysis, blood loss and GPS 1 were independent risk factors for pulmonary complications (p = 0.0118 for blood loss, p = 0.0143 for GPS 1), red blood cell concentration transfusion (p = 0.0036 for blood loss, p = 0.0117 for GPS 1) and flesh frozen plasma transfusion (p = 0.0020 for blood loss, p = 0.0044 for GPS 1). Albumin product transfusion, duration of operation (p = 0.0478), blood loss (p = 0.0420) and GPS 1 (p = 0.0111) were independent risk factors. Disease-free and overall survival of GPS 0 and GPS 1 patients were comparable. CONCLUSION: GPS reflects preoperative patient status, and is associated with blood transfusion and pulmonary complications in elective hepatic resection for HCC.
机译:背景:格拉斯哥预后评分(GPS)证明手术前的全身炎症可预测各种类型癌症的术后并发症和特定于癌症的存活率。这项研究的目的是评估GPS在肝癌肝切除术中的意义。患者与方法:66例行HCC肝切除术的患者被纳入研究。患者分为三组:GPS 0 [C反应蛋白(CRP) / = 3.5 g / dl,n = 54],GPS 1 [CRP> 1.0 mg / dl或血清白蛋白<3.5 g / dl,n = 11]和GPS 2 [CRP> 1.0 mg / dl,血清白蛋白<3.5 g / dl,n = 1]。我们回顾性检查了GPS(0或1)与围手术期临床变量和结局之间的关联。结果:在单因素分析中,GPS 0患者术前15分钟的吲哚菁绿保留率(ICGR15)(p = 0.0418),Child-Pugh分类(p = 0.0075)和终末期肝病评分模型( p = 0.0007)比GPS 1例患者高。在多变量分析中,失血和GPS 1是发生肺部并发症的独立危险因素(失血p = 0.0118,GPS 1失血p = 0.0143),输血红细胞浓度(失血p = 0.0036,GPS失血p = 0.0117) 1)和肉冻血浆输血(失血p = 0.0020,GPS 1 p = 0.0044)。独立的危险因素是输注白蛋白产品,手术时间(p = 0.0478),失血(p = 0.0420)和GPS 1(p = 0.0111)。 GPS 0和GPS 1患者的无病生存期和总体生存率相当。结论:GPS可反映术前患者的状况,并与HCC选择性肝切除术中的输血和肺部并发症有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号